Case Study: NHS lung cancer patient services achieve accelerated diagnosis and dramatically reduced wait times with IQVIA

Lung Cancer Patient Service Provider - Customer Case Study

Lung Cancer Patient Service Provider faced some of the lowest lung cancer survival rates in the UK and needed faster, earlier diagnosis and treatment access, but NHS capacity constraints limited systematic improvement. IQVIA partnered in the PATHFINDER initiative (alongside the NHS and AstraZeneca) and deployed its Market Access and Patient Activation (MAPA) capabilities to help map and reform patient pathways.

IQVIA led quantitative and qualitative analyses, centre deep‑dives and implementation of targeted recommendations to streamline care; pilot sites saw patient review times fall from 5 days to under 24 hours, PET‑CT waits drop from 5–7 days to 2 days, same‑day lab sample delivery rise to 80%, and two findings adopted into GIRFT. These measurable gains reflect IQVIA’s ability to integrate with the NHS, leverage real‑world data and augment capacity to accelerate diagnosis and treatment access across the lung cancer pathway.